SCHEMBL4829946

SCHEMBL4829946

CCc1ccc(S(=O)(=O)On2c(=O)c3cc4c(=O)n(OS(=O)(=O)c5ccc(CC)cc5)c(=O)c4cc3c2=O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VDR P11473 2/20 0.55
ALDH1A1 P00352 2/20 0.55
KDM4E B2RXH2 1/20 0.55
F2 P00734 1/20 0.55
MAPT P10636 1/20 0.55
CA2 P00918 3/20 0.43
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA9 Q16790 2/20 0.42
HSD11B1 P28845 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
TP53 P04637 1/20 0.37
UCHL1 P09936 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HTR6 P50406 1/20 0.36
POLB P06746 2/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12534680 0.84 CA12 (0.42) VDRALDH1A1KDM4EF2MAPT
SCHEMBL4831824 0.83 CA2 (0.49) ALDH1A1KDM4ECA2CA12CA1
SCHEMBL4835154 0.82 VDR (0.53) VDRALDH1A1KDM4EF2MAPT
SCHEMBL4829876 0.80 KMT2A (0.50) VDRALDH1A1KDM4EMAPTCA2
SCHEMBL4834642 0.79 GAA (0.48) CA2CA1CA9NPC1RAB9A
SCHEMBL4836742 0.79 ALDH1A1 (0.46) ALDH1A1KDM4ECA2CA12CA1
SCHEMBL4836943 0.79 CA1 (0.38) VDRALDH1A1KDM4EF2MAPT
SCHEMBL12534653 0.79 CA2 (0.41) VDRALDH1A1KDM4EMAPTCA2
SCHEMBL4835181 0.79 THRB (0.46) VDRALDH1A1KDM4EMAPTCA2
SCHEMBL4826493 0.78 PARL (0.53) VDRALDH1A1KDM4EF2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 VDR 4831/4885ALDH1A1 633/4885KDM4E 2501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.